Nutanix (NTNX) is up 4.1% today. Here is some analysis on what might have caused this price movement.
Analysis: Shares appear to be moving higher on enthusiasm around a new strategic enterprise-AI partnership with AMD that includes a sizable equity investment, plus follow-through from Nutanix’s latest quarterly results. The combination likely reinforced investor expectations for Nutanix’s relevance in enterprise “agentic AI” infrastructure deployments.
Details:
Sources:
AMD Newsroom, The Associated Press, MarketWatch
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$NTNX Insider Trading Activity
$NTNX insiders have traded $NTNX stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $NTNX stock by insiders over the last 6 months:
- RAJIV RAMASWAMI (President and CEO) has made 0 purchases and 2 sales selling 144,707 shares for an estimated $11,059,200.
- RUKMINI SIVARAMAN (Chief Financial Officer) sold 11,391 shares for an estimated $892,414
- BRIAN MARTIN (Chief Legal Officer) sold 10,241 shares for an estimated $783,731
- TERESA GAYLE SHEPPARD has made 0 purchases and 2 sales selling 3,500 shares for an estimated $267,691.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTNX Hedge Fund Activity
We have seen 244 institutional investors add shares of $NTNX stock to their portfolio, and 459 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 5,822,793 shares (-80.0%) from their portfolio in Q4 2025, for an estimated $300,980,170
- AQR CAPITAL MANAGEMENT LLC added 4,826,443 shares (+72.8%) to their portfolio in Q4 2025, for an estimated $249,478,838
- GENERATION INVESTMENT MANAGEMENT LLP removed 3,013,651 shares (-46.8%) from their portfolio in Q4 2025, for an estimated $155,775,620
- FIL LTD added 2,786,929 shares (+180.1%) to their portfolio in Q4 2025, for an estimated $144,056,360
- CITADEL ADVISORS LLC added 2,430,339 shares (+9636.9%) to their portfolio in Q4 2025, for an estimated $125,624,222
- ALYESKA INVESTMENT GROUP, L.P. added 2,425,665 shares (+926.8%) to their portfolio in Q4 2025, for an estimated $125,382,623
- FEDERATED HERMES, INC. removed 2,210,012 shares (-62.1%) from their portfolio in Q4 2025, for an estimated $114,235,520
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NTNX Analyst Ratings
Wall Street analysts have issued reports on $NTNX in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 01/05/2026
- Goldman Sachs issued a "Buy" rating on 11/28/2025
- B of A Securities issued a "Buy" rating on 11/26/2025
- JP Morgan issued a "Overweight" rating on 11/26/2025
- Needham issued a "Buy" rating on 11/26/2025
- Piper Sandler issued a "Overweight" rating on 11/26/2025
- Keybanc issued a "Overweight" rating on 11/26/2025
To track analyst ratings and price targets for $NTNX, check out Quiver Quantitative's $NTNX forecast page.
$NTNX Price Targets
Multiple analysts have issued price targets for $NTNX recently. We have seen 12 analysts offer price targets for $NTNX in the last 6 months, with a median target of $60.0.
Here are some recent targets:
- Wamsi Mohan from B of A Securities set a target price of $60.0 on 02/26/2026
- Mike Cikos from Needham set a target price of $55.0 on 02/26/2026
- Meta Marshall from Morgan Stanley set a target price of $56.0 on 02/24/2026
- Matthew Martino from Goldman Sachs set a target price of $60.0 on 02/09/2026
- Tim Long from Barclays set a target price of $53.0 on 01/15/2026
- Matthew Hedberg from RBC Capital set a target price of $65.0 on 01/05/2026
- Brandon Nispel from Keybanc set a target price of $65.0 on 11/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.